Methyl-CpG Binding Domain 1Gene Polymorphisms and Risk of Primary Lung Cancer
Authors:
Open Access
- 1 November 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 14 (11) , 2474-2480
Abstract
The methyl-CpG binding domain 1 (MBD1) protein plays an important role for transcriptional regulation of gene expression. Polymorphisms and haplotypes of the MBD1 gene may have an influence on MBD1 activity on gene expression profiles, thereby modulating an individual's susceptibility to lung cancer. To test this hypothesis, we investigated the association of MBD1 −634G>A, −501delT (−501 T/T, T/−, −/−), and Pro401Ala genotypes and their haplotypes with the risk of lung cancer in a Korean population. The MBD1 genotype was determined in 432 lung cancer patients and in 432 healthy control subjects who were frequency matched for age and gender. The −634GG genotype was associated with a significantly increased risk of overall lung cancer compared with the −634AA genotype [adjusted odds ratio (OR), 3.10; 95% confidence interval (95% CI), 1.24-7.75; P = 0.016]. When analyses were stratified according to the tumor histology, the −634GG genotype was associated with a significantly increased risk of adenocarcinoma compared with the −634AA genotype (adjusted OR, 4.72; 95% CI, 1.61-13.82; P = 0.005). For the MBD1 −501delT and Pro401Ala polymorphisms, the −501 T/T genotype was associated with a marginal significantly increased risk of adenocarcinoma compared with the −501−/− genotype (adjusted OR, 2.07; 95% CI, 1.02-4.20; P = 0.045), and the Pro/Pro genotype was associated with a significantly increased risk of adenocarcinoma compared with the Ala/Ala genotype (adjusted OR, 3.41; 95% CI, 1.21-9.60; P = 0.02). Consistent with the genotyping analyses, the −634G/−501T/401Pro haplotype was associated with a significantly increased risk of overall lung cancer and adenocarcinoma compared with the −634A/−501−/401Ala haplotype (adjusted OR, 1.44; 95% CI, 1.08-1.91; P = 0.012 and Pc = 0.048; adjusted OR, 1.75; 95% CI, 1.20-2.56; P = 0.004 and Pc = 0.016, respectively). On a promoter assay, the −634A allele had significantly higher promoter activity compared with the −634G allele in the Chinese hamster ovary cells and A549 cells (P < 0.05 and P < 0.001, respectively), but the −501delT polymorphism did not have an effect on the promoter activity. When comparing the promoter activity of the MBD1 haplotypes, the −634A/−501− haplotype had a significantly higher promoter activity than the −634G/−501T haplotype (P < 0.001). These results suggest that the MBD1 −634G>A, −501delT, and Pro401Ala polymorphisms and their haplotypes contribute to the genetic susceptibility for lung cancer and particularly for adenocarcinoma.Keywords
This publication has 36 references indexed in Scilit:
- No Association between Polymorphisms in theHistone DeacetylaseGenes and the Risk of Lung CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- XPC polymorphisms and lung cancer riskInternational Journal of Cancer, 2005
- Vascular Endothelial Growth Factor Gene Polymorphisms and Risk of Primary Lung CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- −93G→A polymorphism of hMLH1 and risk of primary lung cancerInternational Journal of Cancer, 2004
- MCAF Mediates MBD1-Dependent Transcriptional RepressionMolecular and Cellular Biology, 2003
- Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs?Oncogene, 2002
- The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14ARF, p16INK4a and RASSF1A in human lung cancer cell linesOncogene, 2002
- Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancerLung Cancer, 2002
- Methyl CpG binding proteins: coupling chromatin architecture to gene regulationOncogene, 2001
- A component of the transcriptional represser MeCP1 shares a motif with DNA methyltransferase and HRX proteinsNature Genetics, 1997